Abstract

Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy

Author(s): Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola

Issue: May/Jun 2011 - Volume 15, Number 3

Page(s): 214-217

Download in electronic PDF format for $75

Abstract

Metronidazole is a nitroimidazole antibacterial and antiprotozoal agent that is frequently employed in the treatment of clostridial diarrhea but has variable efficacy against Campylobacter. Metronidazole also exhibits trichomonacidal and amebicidal characteristics as well as some inhibitive actions against cell-mediated immunity. Although commercially available in 250- mg and 500-mg tablets as well as a 375-mg capsule for human use, veterinary-approved metronidazole is not commercially available in the doses required for smaller veterinary patients. Metronidazole suspension is, therefore, commonly compounded for the treatment of veterinary patients. This article discusses Clostridium and Campylobacter bacterium as well as a case report of an English Bulldog diagnosed with clostridial and campylobacterial enteritis.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2011 Pg. 214-217	Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy Author(s): Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jan/Feb 2021 Pg. 24-28	Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Author(s): McElhiney Linda F
Mar/Apr 2011 Pg. 114-116	Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine Author(s): Rudner Shara, Pora Amanda, DeMeo Jennifer
Jan/Feb 2011 Pg. 27-31	Goliath: Case Report on a Canine Case of Epilepsy Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 1999 Pg. 34-35	Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor Author(s): Mason Dave
Jan/Feb 2020 Pg. 77-82	Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Jan/Feb 2017 Pg. 22-27	Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Nov/Dec 2008 Pg. 558-564	Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Jul/Aug 2018 Pg. 320	Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
May/Jun 2015 Pg. 248-251	Stability of Metronidazole Suspensions Author(s): Donnelly Ronald F, Ying James
Jul/Aug 2004 Pg. 265-267	Case Report: Wound Care of a Diabetic Foot Ulcer Author(s): Wynn Tom
Sep/Oct 2013 Pg. 380-383	Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease Author(s): McElhiney Linda F
Jan/Feb 2010 Pg. 69	Metronidazole in Normal Saline Enema Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 52	Metronidazole 50 mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr